Response of fetal rabbit ductus arteriosus to bradykinin: Role of nitric oxide, prostaglandins, and bradykinin receptors

被引:11
作者
Bateson, EAJ [1 ]
Schulz, R [1 ]
Olley, PM [1 ]
机构
[1] Univ Alberta, Heritage Med Res Ctr 423, Dept Pediat, Cardiovasc Res Grp, Edmonton, AB T6G 2B7, Canada
关键词
D O I
10.1203/00006450-199904010-00017
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Nitric oxide plays a major role in vascular tone control. Increased blood levels of bradykinin (BK), which stimulates nitric oxide biosynthesis, occur at birth. BK effects on ductus arteriosus (DA) tone were investigated in fetal rabbit under fetal (2.5% O-2 "low Po-2") and neonatal (30% O-2 "high Po-2") conditions using in vitro isometric tension studies. Intact and endothelium-denuded DA, contracted with norepinephrine (ED75-90) showed a biphasic response to BK, with relaxation at 10(-9) to 10(-7) M BK and contraction at 10(-6) to 10(-5) M BK. BK (10(-6) to 10(-5) M) contracted intact DA from baseline tension, with greater contraction under high Po-2. The B-2-receptor antagonist D-Arg-[Hyp(3),Thi(5),D-Tic(7),Oic(8)]-BK (HOe-140, 10(-7) M) abolished relaxation, but not contraction, to BK in intact and denuded DA. The B-1-receptor antagonist des-Arg(9)-[Leu(8)]-BK (10(-7) M) reduced BK-induced contraction but not relaxation in intact DA only. Nitric oxide synthase inhibitors, N-omega-nitro-L-arginine methyl ester (10(-4) M) and N-omega-monomethyl-L-arginine (10(-4) M) partially inhibited relaxation to BK in intact DA, with L-arginine (3 x 10(-4) M) reversing N-omega-monomethyl-L-arginine inhibition. N-omega-nitro-L-arginine methyl ester (10(-4) M) caused a small but significant inhibition of relaxation to BK in denuded DA. Indomethacin (2.8 X 10(-6) M), a cyclooxygenase inhibitor, abolished relaxation but not contraction to BK in intact and denuded DA. BK-induced relaxation of the DA acts through B-2-receptors. releasing both nitric oxide and prostaglandins, whereas endothelial B-1-receptors may mediate contraction. BK action on isolated DA changes from relaxation to contraction as its concentration increases, with greater contraction at neonatal Po-2. Thus increased BK levels at birth may aid functional closure of the DA.
引用
收藏
页码:568 / 574
页数:7
相关论文
共 34 条
[11]   MECHANISM UNDERLYING SUBSTANCE-P-INDUCED RELAXATION IN DOG ISOLATED SUPERFICIAL TEMPORAL ARTERIES [J].
ENOKIBORI, M ;
OKAMURA, T ;
TODA, N .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (01) :77-82
[12]   AGONISTIC AND ANTAGONISTIC PROPERTIES OF THE BRADYKININ B-2 RECEPTOR ANTAGONIST, HOE-140, IN ISOLATED BLOOD-VESSELS FROM DIFFERENT SPECIES [J].
FELETOU, M ;
GERMAIN, M ;
THURIEAU, C ;
FAUCHERE, JL ;
CANET, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :683-689
[13]   Human vascular kinin receptors of the B-2 type characterized by radioligand binding [J].
Gessi, S ;
Rizzi, A ;
Calo, G ;
Agnello, G ;
Jorizzo, G ;
Mollica, G ;
Borea, PA ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (07) :1450-1454
[14]   Effects of the non-peptide B-2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release [J].
Griesbacher, T ;
Sametz, W ;
Legat, FJ ;
Diethart, S ;
Hammer, S ;
Juan, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (03) :469-476
[15]   CLOSURE OF DUCTUS-ARTERIOSUS IN PREMATURE-INFANTS BY INHIBITION OF PROSTAGLANDIN SYNTHESIS [J].
HEYMANN, MA ;
RUDOLPH, AM ;
SILVERMAN, NH .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (10) :530-533
[16]  
HOCH FJ, 1991, BRIT J PHARMACOL, V102, P769
[17]   RESPONSE OF ISOLATED DUCTUS ARTERIOSUS TO OXYGEN AND ANOXIA [J].
KOVALCIK, V .
JOURNAL OF PHYSIOLOGY-LONDON, 1963, 169 (01) :185-&
[18]  
LLONA I, 1987, J PHARMACOL EXP THER, V241, P608
[19]   Bradykinin-induced contractions of canine saphenous veins: Mediation by B-2 receptors and involvement of eicosanoids [J].
Marsault, R ;
Illiano, S ;
Vanhoutte, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (02) :215-220
[20]   KININS - POSSIBLE MEDIATORS OF NEONATAL CIRCULATORY CHANGES IN MAN [J].
MELMON, KL ;
CLINE, MJ ;
HUGHES, T ;
NIES, AS .
JOURNAL OF CLINICAL INVESTIGATION, 1968, 47 (06) :1295-&